Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorLARMARANGE, J.
dc.contributor.authorDIALLO, M. H.
dc.contributor.authorMCGRATH, N.
dc.contributor.authorIWUJI, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPLAZY, Melanie
hal.structure.identifierStatistics In System biology and Translational Medicine [SISTM]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorTHIEBAUT, Rodolphe
dc.contributor.authorTANSER, F.
dc.contributor.authorBARNIGHAUSEN, T.
dc.contributor.authorPILLAY, D.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDABIS, Francois
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorORNE-GLIEMANN, Joanna
dc.date.accessioned2020-11-30T08:43:08Z
dc.date.available2020-11-30T08:43:08Z
dc.date.issued2018-07
dc.identifier.issn1758-2652 (Electronic) 1758-2652 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/21247
dc.description.abstractEnINTRODUCTION: The universal test and treat strategy (UTT) was developed to maximize the proportion of all HIV-positive individuals on antiretroviral treatment (ART) and virally suppressed, assuming that it will lead to a reduction in HIV incidence at the population level. The evolution over time of the cross-sectional HIV care cascade is determined by individual longitudinal trajectories through the HIV care continuum and underlying population dynamics. The purpose of this paper is to quantify the contribution of each component of population change (in- and out-migration, HIV seroconversion, ageing into the cohort and definitive exit such as death) on the HIV care cascade in the context of the ANRS 12249 Treatment as Prevention (TasP) cluster-randomized trial, investigating UTT in rural KwaZulu-Natal, South Africa, between 2012 and 2016. METHODS: HIV test results and information on clinic visits, ART prescriptions, viral load and CD4 count, migration and deaths were used to calculate residency status, HIV status and HIV care status for each individual on a daily basis. Position within the HIV care continuum was considered as a score ranging from 0 (undiagnosed) to 4 (virally suppressed). We compared the cascade score of each individual joining or leaving the population of resident adults living with HIV with the average score of their cluster at the time of entry or exit. Then, we computed the contribution of each entry or exit on the average cascade score and their annualized total contribution, by component of change. RESULTS: While the average cascade score increased over time in all clusters, that increase was constrained by population dynamics. Permanent exits and ageing into the people living with HIV cohort had a marginal effect. Both in-migrants and out-migrants were less likely to be retained at each step of the HIV care continuum. However, their overall impact on the cross-sectional cascade was limited as the effect of in- and out-migration balanced each other. The contribution of HIV seroconversions was negative in all clusters. CONCLUSIONS: In a context of high HIV incidence, the continuous flow of newly infected individuals slows down the efforts to increase ART coverage and population viral suppression, ultimately attenuating any population-level impact on HIV incidence. CLINICAL TRIAL NUMBER: NCT01509508 (clinicalTrials.gov)/DOH-27-0512-3974 (South African National Clinical Trials Register).
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enIDLIC
dc.subject.enSISTIM
dc.subject.enTasP
dc.title.enThe impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa)
dc.title.alternativeJ Int AIDS Socen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1002/jia2.25128en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30027600en_US
bordeaux.journalJournal of the International AIDS Societyen_US
bordeaux.pagee25128en_US
bordeaux.volume21en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issueSuppl 4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamIDLICen_US
bordeaux.teamSISTIMen_US
bordeaux.teamTasPen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03160878
hal.version1
hal.date.transferred2021-03-05T14:42:39Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.date=2018-07&rft.volume=21&rft.issue=Suppl%204&rft.spage=e25128&rft.epage=e25128&rft.eissn=1758-2652%20(Electronic)%201758-2652%20(Linking)&rft.issn=1758-2652%20(Electronic)%201758-2652%20(Linking)&rft.au=LARMARANGE,%20J.&DIALLO,%20M.%20H.&MCGRATH,%20N.&IWUJI,%20C.&PLAZY,%20Melanie&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée